Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. (CLDX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cldx · stock forecast · 19 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 19 Wall Street analysts in the past 3 months
Buy
19 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$54.00
Consensus
$51.00
+79.0% upside
Low
$48.00
Median: $51 · Last Close: $28.49
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$51.00
79.0% upside
High Target
$54
89.6%
Low Target
$48
68.5%
Current Price
$28.49
as of today
Based on analyst price targets, the CLDX stock price prediction for the next 12 months ranges from $48 to $54. The consensus CLDX price forecast of $51.00 implies 79.0% upside from the current price of $28.49.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $27.49 | ↓ 3.48% |
1-day model range: $27.37–$27.62. Peak: $27.62 (-3.48%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $21 | -27.5% |
| 2028 | $18 | -38.4% |
| 2029 | $16 | -43.5% |
| 2030 | $15 | -46.1% |
| 2031 | — | -47.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CLDX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-05-08 | Barclays | Maintains | Overweight→Overweight |
| 2026-04-20 | Barclays | Upgrade ↑ | Underweight→Overweight |
| 2026-03-02 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2026-02-26 | Stifel | Maintains | Buy→Buy |
| 2025-12-17 | Barclays | Maintains | Underweight→Underweight |
| 2025-11-11 | Barclays | Maintains | Underweight→Underweight |
| 2025-09-17 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-08-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-20 | Citigroup | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Celldex Therapeutics, Inc. (CLDX) stock. Of the recent 115 rating actions, 2 were upgrades and 13 were downgrades. 19 analysts currently cover CLDX.
Analyst Recommendation Trends
CLDX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 98.4% YoY
Revenue Next Year
$8M
↑ 245.2% YoY
EPS This Year
$-4.35
EPS Next Year
$-4.40
↑ 1.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast CLDX EPS of $-4.35 for the current fiscal year, based on estimates from 8 analysts. The CLDX revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CLDX stock forecast is supported by two independent data sources: analyst consensus ratings from 19 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CLDX price target is $51.00 (+79.0% upside), with an analyst consensus of Buy.
The CLDX short-term stock prediction for tomorrow is $27.49 (-3.48%). The CLDX stock price prediction for 2027 estimates an average of $21. The CLDX stock prediction for 2030 projects a range of $15–$16.
Celldex Therapeutics, Inc. trades on NASDAQ under the ticker CLDX. The CLDX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 89% of covering analysts.
Frequently asked questions
CLDX forecast · 8 questionsAccording to 19 Wall Street analysts, the average 12-month CLDX price target is $51.00, with a high forecast of $54.00 and a low of $48.00. The median price target is shown in the chart above when available. This implies +79.0% potential upside from the current price of $28.49.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.